Esperion Therapeutics Inc
(LTS:0IIM)
$
2.135
0.1668 (8.47%)
Market Cap: 424.83 Mil
Enterprise Value: 504.66 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 50/100 Esperion Therapeutics Inc at Stifel Virtual Healthcare Conference Transcript
Nov 17, 2020 / 01:40PM GMT
Release Date Price:
$28.49
Derek Christian Archila
Stifel, Nicolaus & Company, Incorporated, Research Division - Director & Senior Analyst
All right. Good morning, everyone, and welcome to day 2 of the Stifel Healthcare Conference. I'm Derek Archila, one of the senior biotech analyst here at Stifel. I'm pleased to be joined by our next presenter, Esperion Therapeutics. From the company, we have CEO, Tim Mayleben, to the left there; and then we have Rick Bartram, CFO, to the right there. Gentlemen, thank you so much for joining us.
Timothy M. Mayleben
Esperion Therapeutics, Inc. - President, CEO & Director
Good morning, Derek. Thanks for having us. Look forward to the discussion.
Derek Christian Archila;Timothy M. Mayleben
Stifel, Nicolaus & Company, Incorporated, Research Division - Director & Senior Analyst;Esperion
All right. Well, maybe just to start. Maybe, Tim, do you want to just do a brief intro of what you guys have been up to and then we can kind of dig into the Q&A here?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot